Nexus Pharmaceuticals
Richard McMahon is an experienced R&D Analytical Scientist, currently holding the position of R&D Analytical Scientist III at Nexus Pharmaceuticals since February 2022, after progressing from R&D Analytical Scientist II. Prior to this, Richard worked at Fresenius Kabi USA from January 2016 to February 2022 as Senior Scientist I&D, where responsibilities included technical analysis and sample testing for OOS investigations, method development for controlled substances, and validation of analytical methods. Earlier roles include Scientist I&D, where Richard developed various testing methods, and Analytical Development Co-Op, with a focus on gas chromatography. Richard's academic background includes a Master of Science in Biotechnology from Northwestern University and a Bachelor of Science in Cell, Molecular, and Developmental Biology from Purdue University.
This person is not in the org chart
Nexus Pharmaceuticals
Nexus Pharmaceuticals is a US-based, family-owned, minority-owned healthcare company and proud diverse supplier. We specialize in innovative processes to make difficult-to-manufacture specialty drugs that are easier to use, less labor-intensive, and more streamlined in practice. Nexus ensures that its high-quality, FDA-approved drugs fulfill a critical, unmet medical need and delivers dependable life-saving treatment options when and where they’re needed most. We are in the process of building Project Tomorrow – a state-of-the-art manufacturing facility in Pleasant Prairie, Wisconsin and only project of its kind in the last 30 years. Read about our commitment to Wisconsin and see our progress at nexuspharma.net/project-tomorrow